0001104659-25-002053.txt : 20250108 0001104659-25-002053.hdr.sgml : 20250108 20250108163159 ACCESSION NUMBER: 0001104659-25-002053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250106 FILED AS OF DATE: 20250108 DATE AS OF CHANGE: 20250108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sailer Carl CENTRAL INDEX KEY: 0001854182 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40536 FILM NUMBER: 25518924 MAIL ADDRESS: STREET 1: 4 GREENBRIAR LANE CITY: MONTVALE STATE: NJ ZIP: 07645 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acurx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001736243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 259 LIBERTY AVENUE CITY: STATEN ISLAND STATE: NY ZIP: 10305 BUSINESS PHONE: 917-533-1469 MAIL ADDRESS: STREET 1: 259 LIBERTY AVENUE CITY: STATEN ISLAND STATE: NY ZIP: 10305 FORMER COMPANY: FORMER CONFORMED NAME: Acurx Pharmaceuticals, LLC DATE OF NAME CHANGE: 20180402 4 1 tm252665-5_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2025-01-06 0 0001736243 Acurx Pharmaceuticals, Inc. ACXP 0001854182 Sailer Carl C/O ACURX PHARMACEUTICALS, INC., 259 LIBERTY AVENUE STATEN ISLAND NY 10305 1 0 0 0 0 Common Stock 2025-01-06 4 P 0 24631 1.015 A 137183 D Common Stock 5000 I By Spouse Warrants for Common Stock 0.90 2025-01-06 4 P 0 24631 0 A 2025-01-07 2030-01-07 Common Stock 24631 24631 D Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc. Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock. /s/ Kostantinos Skordalos, Power of Attorney For: Carl V. Sailer 2025-01-08